Incyte | Capital Ordinário



Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Gilead Sciences USD 1.24B 3M 2025-06
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
PTC Therapeutics USD 79.38M 79.3M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Incyte Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.